A copy of the article’s visual abstract was erroneously published as the supplemental data file. It has been replaced by the correct supplemental data file.
© 2020 by The American Society of Hematology
2020
Skip Nav Destination
ERRATUM|
August 10, 2020
Von Drygalski A, Giermasz A, Castaman G, et al. Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia B. Blood Adv. 2019;3(21):3241-3247.
Blood Adv (2020) 4 (15): 3668.
Article history
Submitted:
July 17, 2020
Accepted:
July 17, 2020
